Literature DB >> 2957719

Receptor blocking drugs and amphetamine anorexia in human subjects.

E Goodall, E Trenchard, T Silverstone.   

Abstract

The interaction between the receptor antagonist thymoxamine (THYM), propranolol (PPL) and metergoline (MTG) with dexamphetamine (d-Amp)-induced anorexia was examined in a series of studies in normal female volunteers. Visual analogue scale (VAS) ratings of hunger were made and food intake was measured using an automated solid food dispenser (AFD). d-Amp (10 mg) significantly depressed hunger ratings compared to placebo in two of the three studies and its effect was countered by the addition of MTG (4 mg). d-Amp significantly reduced food intake compared to placebo in two studies. In all trials the reduction in food intake following d-Amp was significantly greater than would have been predicted from its effect on hunger. THYM (160 mg) and PPL (40 mg) were associated with no changes in food intake when given alone or with d-Amp, MTG increased food intake (but not significantly) and the combined effects of MTG and d-Amp was the algebraic sum of the effect of each; but there appeared to be no true pharmacological interaction between blocker and anorectic. The results indicated that there may be some dissociation between the effect of d-Amp on hunger and food intake but have failed to produce evidence that noradrenergic pathways are involved. The results are consistent with the theories that d-Amp anorexia does not involve the release of 5-hydroxytryptamine (5-HT) but that 5-HT pathways are involved in the feeding process.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2957719     DOI: 10.1007/bf00176483

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  14 in total

1.  Propranolol on tests of visual function and central nervous activity.

Authors:  P C Bryan; D O Efiong; J Stewart-Jones; P Turner
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

2.  Amphetamine anorexia: antagonism by typical but not atypical neuroleptics.

Authors:  S L Burridge; J E Blundell
Journal:  Neuropharmacology       Date:  1979-05       Impact factor: 5.250

3.  Release by amphetamine in man of growth hormone and corticosteroids: the effects of thymoxamine and propranolol.

Authors:  G M Besser; P W Butler; J G Ratcliffe; L Rees; P Young
Journal:  Br J Pharmacol       Date:  1970-05       Impact factor: 8.739

4.  Role of monoamines in the anorexigenic actions of fenfluramine, amphetamine and p-chloromethamphetamine.

Authors:  B V Clineschmidt; J C Mcguffin; A B Werner
Journal:  Eur J Pharmacol       Date:  1974-08       Impact factor: 4.432

5.  The effect of the dopamine receptor blocking drug pimozide on the stimulant and anorectic actions of dextroamphetamine in man.

Authors:  T Silverstone; J Fincham; B Wells; M Kyriakides
Journal:  Neuropharmacology       Date:  1980-12       Impact factor: 5.250

6.  Inhibition of prolactin release by metergoline administration in man.

Authors:  G Delitala; A Masala; S Alagna; L Devilla; P P Rovasio
Journal:  Biomedicine       Date:  1977-01-31

7.  Feeding stimulated by very low doses of d-amphetamine administered systemically or by microinjection into the striatum.

Authors:  P Winn; S F Williams; L J Herberg
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  The effect of propranolol phentolamine and pimozide on drug-induced anorexia in the mouse.

Authors:  S Dobrzanski; N S Doggett
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

9.  Anorexigenic effects of d-amphetamine and l-DOPA in the rat.

Authors:  I S Sanghvi; G Singer; E Friedman; S Gershon
Journal:  Pharmacol Biochem Behav       Date:  1975 Jan-Feb       Impact factor: 3.533

10.  Characterisation of adjustments to the structure of feeding behaviour following pharmacological treatment: effects of amphetamine and fenfluramine and the antagonism produced by pimozide and methergoline.

Authors:  J E Blundell; C J Latham
Journal:  Pharmacol Biochem Behav       Date:  1980-05       Impact factor: 3.533

View more
  2 in total

Review 1.  Options for the management of obesity.

Authors:  P L Beales; P G Kopelman
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

Review 2.  Functional diversity of ventral midbrain dopamine and GABAergic neurons.

Authors:  Tatiana M Korotkova; Alexei A Ponomarenko; Ritchie E Brown; Helmut L Haas
Journal:  Mol Neurobiol       Date:  2004-06       Impact factor: 5.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.